Impact of age on outcomes following continuous-flow left ventricular assist device implantation

Interactive Cardiovascular and Thoracic Surgery

Volumn 20, Issue 6, 2015, Pages 743-748

  Lushaj, Entela B ^a   Badami, Abbasali ^a   Osaki, Satoru ^a   Murray, Margaret ^a   Leverson, Glen ^a   Lozonschi, Lucian ^a   Akhter, Shahab ^a   Kohmoto, Takushi ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Adult; Circulatory support devices; Outcomes

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEVICE INFECTION; DEVICE THERAPY; FEMALE; HEART FAILURE; HEART GRAFT; HEART INDEX; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTHROMBIN TIME; RETREATMENT; RETROSPECTIVE STUDY; RIGHT VENTRICULAR ASSIST DEVICE; SODIUM BLOOD LEVEL; SURVIVAL TIME; COMPARATIVE STUDY; CONVALESCENCE; DISEASE COURSE; HEART ASSIST DEVICE; HEART LEFT VENTRICLE FUNCTION; HEART TRANSPLANTATION; KAPLAN MEIER METHOD; PATHOPHYSIOLOGY; PATIENT SELECTION; PROPORTIONAL HAZARDS MODEL; PROSTHESIS DESIGN; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

AGE FACTORS; AGED; COMORBIDITY; DISEASE PROGRESSION; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84930808528     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivv051     Document Type: Article

References (13)

1. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, et al. Sixth INTERMACS annual report: a 10, 000-patients database. J Heart Lung Transplant 2014; 33: 555-64
2. Mallidi HR, Anand J, Cohn WE. State of the art of mechanical circulatory support. Tex Heart Inst J 2014; 1: 115-20
3. Sabashnikov A, Mohite PN, Weymann A, Patil NP, Hedger M, Sáez DG, et al. Outcomes after implantation of 139 full support continuous-flow left ventricular assist devices as a bridge to transplantation. Eur J Cardiothorac Surg 2014; 46: e59-66
4. Sabashnikov A, Mohite PN, Zych B, García D, Popov AF, Weymann A, et al. Outcomes and predictors of early mortality after continuous-flow left ventricular assist device implantation as a bridge to transplantation. ASAIO J 2014; 60: 162-9
5. Huang R, Deng M, Rogers JG, Howser R, Portner PM, Pierson RN, et al. Effect of age on outcomes after left ventricular assist device placement. Transplant Proc 2006; 38: 1496-8
6. Weiss ES, Nwakanma LU, Patel ND, Yuh DD. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database. J Heart Lung Transplant 2008; 27: 184-91
7. Kwon MH, Moriguchi JD, Ardehali A. Use of ventricular assist device as a bridge to cardiac transplantation: impact of age and other determinants on outcomes. Tex Heart Inst J 2009; 36: 214-9
8. Sandner SE, Zimpfer D, Zrunek P. Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation. J Heart Lung Transplant 2009; 28: 367-72
9. Pulikottil-Jacob R, Suri G, Connock M, Kandala NB, Sutcliffe P, Maheswaran H, et al. Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service bridge-To-Transplant program for patients with heart failure. J Heart Lung Transplant 2014; 33: 350-8
10. Lalonde SD, Alba AC, Rigobon A, Ross HJ, Delgado DH, Billia F, et al. Clinical differences between continuous flow ventricular assist devices: a comparison between HeartMate II and HeartWare HVAD. J Card Surg 2013; 28: 604-10
11. Murray AM, Osaki S, Edwards NM, Johnson MR, Bobadilla LJ, Gordona EA, et al. Multidisciplinary approach decreases length of stay and reduces cost for ventricular assist device therapy. Interact CardioVasc Thorac Surg 2009; 8: 84-8
12. Frazier OH, Rose EA, Oz MC. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 2011; 122: 1186-95
13. Rao V, Oz MC, Flannery MA, Catanese KA, Argenziano M, Naka Y. Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg 2003; 125: 855-62